Effects of mGluR5 Antagonists on Parkinson's Patients With L-Dopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Modulation of Metabotropic glutamate receptor 5 (mGluR5) may be a novel therapeutic approach to manage Parkinson's disease (PD) Patients with L-dopa-induced dyskinesia (LID). Objectives: The objective of this meta-analysis was to evaluate the effects of mGluR5 antagonists for the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen-Wen, Zhang, Xing-Ru, Zhang, Zeng-Rui, Wang, Xin-Shi, Chen, Jie, Chen, Si-Yan, Xie, Cheng-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142875/
https://www.ncbi.nlm.nih.gov/pubmed/30271338
http://dx.doi.org/10.3389/fnagi.2018.00262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142875/
https://www.ncbi.nlm.nih.gov/pubmed/30271338
http://dx.doi.org/10.3389/fnagi.2018.00262

Ejemplares similares